Anesthetic Products Recalled

HTO Nevada Inc is recalling 2 types of anesthetics used by licensed professionals to reduce pain during procedures. According to the February 22, 2022, US Food and Drug Administration (FDA) Enforcement Report, discolored epinephrine prompted the recall. 

The recall affects the following products, which were distributed by Dermal Source, Portland, OR, throughout the United States and Canada:

• New & Improved Blue Gel Anesthetic (lidocaine HCL 5%, tetracaine HCL 1%, and epinephrine 0.1%), 1 oz bottle (NDC 80069-008-01), from lots 796CP-0006 (Exp 2/24) and 796CP-0007 (Exp 3/24); and
• Maximum Zone 2 Topical Analgesic (lidocaine HCL 5%, epinephrine 0.01%), 1 oz bottle (NDC 80069-012-01), from lot 795CP-0003 (Exp 7/24).

HTO Nevada voluntarily initiated the recalls February 9, 2023. 

On February 15, 2023, the FDA designated the recalls Class II. Products affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists.